Bank of America’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $921K | Sell |
96,080
-74,201
| -44% | -$712K | ﹤0.01% | 4499 |
|
|
2025
Q1 | $1.07M | Buy |
170,281
+3,776
| +2% | +$23.7K | ﹤0.01% | 4314 |
|
|
2024
Q4 | $1.35M | Buy |
166,505
+62,726
| +60% | +$509K | ﹤0.01% | 4027 |
|
|
2024
Q3 | $1.88M | Buy |
103,779
+5,747
| +6% | +$104K | ﹤0.01% | 3893 |
|
|
2024
Q2 | $1.01M | Sell |
98,032
-7,823
| -7% | -$80.6K | ﹤0.01% | 4172 |
|
|
2024
Q1 | $1.12M | Buy |
105,855
+24,062
| +29% | +$256K | ﹤0.01% | 4102 |
|
|
2023
Q4 | $747K | Buy |
81,793
+28,235
| +53% | +$258K | ﹤0.01% | 4349 |
|
|
2023
Q3 | $555K | Sell |
53,558
-2,524
| -5% | -$26.2K | ﹤0.01% | 4428 |
|
|
2023
Q2 | $803K | Sell |
56,082
-197,403
| -78% | -$2.83M | ﹤0.01% | 4160 |
|
|
2023
Q1 | $1.81M | Buy |
253,485
+188,023
| +287% | +$1.34M | ﹤0.01% | 3785 |
|
|
2022
Q4 | $734K | Sell |
65,462
-5,286
| -7% | -$59.3K | ﹤0.01% | 4429 |
|
|
2022
Q3 | $784K | Sell |
70,748
-20,796
| -23% | -$230K | ﹤0.01% | 4355 |
|
|
2022
Q2 | $772K | Buy |
91,544
+24,884
| +37% | +$210K | ﹤0.01% | 4441 |
|
|
2022
Q1 | $908K | Sell |
66,660
-7,731
| -10% | -$105K | ﹤0.01% | 4696 |
|
|
2021
Q4 | $1.46M | Buy |
74,391
+9,857
| +15% | +$194K | ﹤0.01% | 4191 |
|
|
2021
Q3 | $2.07M | Buy |
64,534
+990
| +2% | +$31.8K | ﹤0.01% | 3767 |
|
|
2021
Q2 | $2.15M | Sell |
63,544
-1,460
| -2% | -$49.4K | ﹤0.01% | 3681 |
|
|
2021
Q1 | $2.44M | Buy |
65,004
+25,025
| +63% | +$940K | ﹤0.01% | 3586 |
|
|
2020
Q4 | $1.33M | Buy |
39,979
+34,945
| +694% | +$1.16M | ﹤0.01% | 3679 |
|
|
2020
Q3 | $184K | Buy |
5,034
+479
| +11% | +$17.5K | ﹤0.01% | 4745 |
|
|
2020
Q2 | $150K | Sell |
4,555
-11,188
| -71% | -$368K | ﹤0.01% | 4892 |
|
|
2020
Q1 | $406K | Buy |
15,743
+13,888
| +749% | +$358K | ﹤0.01% | 4128 |
|
|
2019
Q4 | $58K | Buy |
+1,855
| New | +$58K | ﹤0.01% | 5388 |
|